deltatrials
Completed NA INTERVENTIONAL 2-arm NCT04595968

Electrical Vestibular Nerve Stimulation (VeNS) Compared to Sham Control As a Means of Improving Glycemic Control in Adults with Type 2 Diabetes Mellitus

A Randomized, Double Blind Sham Controlled Clinical Trial to Evaluate the Efficacy of Vestibular Nerve Stimulation (VeNS), Together with a Lifestyle Modification Program, Compared to a Sham Control with a Lifestyle Modification Program, As a Means of Improving Glycemic Control in Adults with Type 2 Diabetes Mellitus

Sponsor: CS Lifescience

Updated 20 times since 2020 Last updated: Sep 9, 2024 Started: May 21, 2021 Primary completion: Aug 6, 2024 Completion: Aug 6, 2024
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Type 2 Diabetes, this trial is completed. The trial is conducted by CS Lifescience and has accumulated 20 data snapshots since 2021. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Nov 2020 – ~Jan 2021 · 2 months · monthly snapshot~Jan 2021 – ~Apr 2021 · 3 months · monthly snapshot~Apr 2021 – ~Jun 2021 · 2 months · monthly snapshot~Jun 2021 – ~Feb 2022 · 8 months · monthly snapshot~Feb 2022 – ~May 2022 · 3 months · monthly snapshot~May 2022 – ~Sep 2022 · 4 months · monthly snapshot~Sep 2022 – ~Dec 2022 · 3 months · monthly snapshot~Dec 2022 – ~May 2023 · 5 months · monthly snapshot~May 2023 – ~Sep 2023 · 4 months · monthly snapshot~Sep 2023 – ~Nov 2023 · 2 months · monthly snapshot~Nov 2023 – ~Jan 2024 · 2 months · monthly snapshot~Jan 2024 – ~Feb 2024 · 31 days · monthly snapshot~Feb 2024 – ~Apr 2024 · 2 months · monthly snapshot~Apr 2024 – ~Jun 2024 · 2 months · monthly snapshot~Jun 2024 – ~Jul 2024 · 30 days · monthly snapshot~Jul 2024 – ~Aug 2024 · 31 days · monthly snapshot~Aug 2024 – ~Sep 2024 · 31 days · monthly snapshot~Sep 2024 – ~Oct 2024 · 30 days · monthly snapshot~Oct 2024 – ~Sep 2025 · 11 months · monthly snapshot~Sep 2025 – present · 10 months · monthly snapshot

Change History

20 versions recorded
  1. Sep 2025 — Present [monthly]

    Completed NA

  2. Oct 2024 — Sep 2025 [monthly]

    Completed NA

  3. Sep 2024 — Oct 2024 [monthly]

    Completed NA

    Status: Active Not RecruitingCompleted

  4. Aug 2024 — Sep 2024 [monthly]

    Active Not Recruiting NA

  5. Jul 2024 — Aug 2024 [monthly]

    Active Not Recruiting NA

Show 15 earlier versions
  1. Jun 2024 — Jul 2024 [monthly]

    Active Not Recruiting NA

  2. Apr 2024 — Jun 2024 [monthly]

    Active Not Recruiting NA

    Status: RecruitingActive Not Recruiting

  3. Feb 2024 — Apr 2024 [monthly]

    Recruiting NA

  4. Jan 2024 — Feb 2024 [monthly]

    Recruiting NA

  5. Nov 2023 — Jan 2024 [monthly]

    Recruiting NA

  6. Sep 2023 — Nov 2023 [monthly]

    Recruiting NA

  7. May 2023 — Sep 2023 [monthly]

    Recruiting NA

  8. Dec 2022 — May 2023 [monthly]

    Recruiting NA

  9. Sep 2022 — Dec 2022 [monthly]

    Recruiting NA

  10. May 2022 — Sep 2022 [monthly]

    Recruiting NA

  11. Feb 2022 — May 2022 [monthly]

    Recruiting NA

  12. Jun 2021 — Feb 2022 [monthly]

    Recruiting NA

    Status: Not Yet RecruitingRecruiting

  13. Apr 2021 — Jun 2021 [monthly]

    Not Yet Recruiting NA

  14. Jan 2021 — Apr 2021 [monthly]

    Not Yet Recruiting NA

  15. Nov 2020 — Jan 2021 [monthly]

    Not Yet Recruiting NA

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • CS Lifescience
  • Clinical Trial Mentors
  • Neurovalens Ltd.
  • University College Dublin
Data source: Neurovalens Ltd.

For direct contact, visit the study record on ClinicalTrials.gov .